ATE234089T1 - Zubereitungen enthaltend sclareol und sclareolide zur behandlung mikrobieller infektionen - Google Patents

Zubereitungen enthaltend sclareol und sclareolide zur behandlung mikrobieller infektionen

Info

Publication number: ATE234089T1
Authority: AT; Austria
Prior art keywords: sclareolides; treatment; disorders; preparations containing; microbial infections
Prior art date: 1998-06-09

Application number

AT99921939T

Other languages

English (en)

Inventor

Ven Subbiah

Original Assignee

Reynolds Tobacco Co R

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-09

Filing date

1999-05-12

Publication date

2003-03-15

1999-05-12 Application filed by Reynolds Tobacco Co R filed Critical Reynolds Tobacco Co R

2003-03-15 Application granted granted Critical

2003-03-15 Publication of ATE234089T1 publication Critical patent/ATE234089T1/de

Links

208000015181 infectious disease Diseases 0.000 title abstract 2
230000000813 microbial effect Effects 0.000 title abstract 2
XVULBTBTFGYVRC-HHUCQEJWSA-N sclareol Chemical compound CC1(C)CCC[C@]2(C)[C@@H](CC[C@](O)(C)C=C)[C@](C)(O)CC[C@H]21 XVULBTBTFGYVRC-HHUCQEJWSA-N 0.000 title 2
XVULBTBTFGYVRC-UHFFFAOYSA-N Episclareol Natural products CC1(C)CCCC2(C)C(CCC(O)(C)C=C)C(C)(O)CCC21 XVULBTBTFGYVRC-UHFFFAOYSA-N 0.000 title 1
LAEIZWJAQRGPDA-UHFFFAOYSA-N Manoyloxid Natural products CC1(C)CCCC2(C)C3CC=C(C)OC3(C)CCC21 LAEIZWJAQRGPDA-UHFFFAOYSA-N 0.000 title 1
238000002360 preparation method Methods 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 5
150000001875 compounds Chemical class 0.000 abstract 3
238000009472 formulation Methods 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
208000002874 Acne Vulgaris Diseases 0.000 abstract 1
206010000496 acne Diseases 0.000 abstract 1
230000004913 activation Effects 0.000 abstract 1
102000030621 adenylate cyclase Human genes 0.000 abstract 1
108060000200 adenylate cyclase Proteins 0.000 abstract 1
230000001580 bacterial effect Effects 0.000 abstract 1
239000002537 cosmetic Substances 0.000 abstract 1
230000002538 fungal effect Effects 0.000 abstract 1
230000007246 mechanism Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Birds (AREA)
Dermatology (AREA)
Emergency Medicine (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT99921939T 1998-06-09 1999-05-12 Zubereitungen enthaltend sclareol und sclareolide zur behandlung mikrobieller infektionen ATE234089T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/094,058 US6150381A (en)	1998-06-09	1998-06-09	Methods of treating microbial infection and therapeutic formulations therefor
PCT/US1999/010534 WO1999063978A2 (en)	1998-06-09	1999-05-12	Methods of treating microbial infection and therapeutic formulations therefor

Publications (1)

Publication Number	Publication Date
ATE234089T1 true ATE234089T1 (de)	2003-03-15

Family

ID=22242608

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99921939T ATE234089T1 (de)	1998-06-09	1999-05-12	Zubereitungen enthaltend sclareol und sclareolide zur behandlung mikrobieller infektionen

Country Status (6)

Country	Link
US (2)	US6150381A (de)
EP (1)	EP1083895B1 (de)
AT (1)	ATE234089T1 (de)
AU (1)	AU3902299A (de)
DE (1)	DE69905878T2 (de)
WO (1)	WO1999063978A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6150381A (en) *	1998-06-09	2000-11-21	R.J. Reynolds Tobacco Company	Methods of treating microbial infection and therapeutic formulations therefor
DE19853476A1 (de) *	1998-11-19	2000-05-31	Bionorica Arzneimittel Gmbh	Prolaktin-senkendes Mittel
DK1272154T3 (da) *	2000-04-04	2005-01-31	Color Access Inc	Præparat til forbedring af hudlipidbarrierefunktionen
DE10048596A1 (de) *	2000-09-30	2002-04-25	Henkel Kgaa	Entzündungshemmende Wirkstoffe
US20020142013A1 (en) *	2001-01-31	2002-10-03	Maes Daniel H.	Cholesterol sulfate and amino sugar compositions for enhancement of stratum corneum function
US20030072777A1 (en) *	2001-10-05	2003-04-17	Maes Daniel H.	Combinatorial anti-acne compositions
US20040018220A1 (en) *	2002-07-26	2004-01-29	Chiou Consulting, Inc.	Aqueous compositions for facial cosmetics
US20040167223A1 (en) *	2002-09-03	2004-08-26	Popp Karl F.	Topical antibacterial formulations
US20040171561A1 (en) *	2002-09-03	2004-09-02	Popp Karl F.	Topical formulations for treatment of rosacea
CN1946368B (zh) *	2004-04-30	2012-05-09	花王株式会社	皱纹改善剂及皮肤化妆品
US7588759B2 (en) *	2004-12-17	2009-09-15	Avoca, Inc.	Compositions comprising sclareol or derivatives thereof and uses thereof
EP2014276A1 (de)	2007-06-20	2009-01-14	Cognis IP Management GmbH	Kosmetische Zusammensetzungen mit Sclareolid- und Hesperidin-Methyl-Chalcon
US20100317635A1 (en)	2009-06-16	2010-12-16	Endorecherche, Inc.	Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
EP2789369B1 (de)	2013-04-14	2018-06-06	Symrise AG	Eine Zubereitung zur Aufhellung von Haut und Haaren
EP3097905B1 (de)	2015-05-28	2020-11-04	Symrise AG	Kosmetische zubereitungen
CN109562046A (zh)	2016-05-30	2019-04-02	西姆莱斯股份公司	含有香紫苏内酯的化妆品组合物
US11071701B2 (en)	2016-06-30	2021-07-27	Symrise Ag	Medicament and cosmetic composition comprising resorcinol derivatives
US20190247449A1 (en) *	2016-09-14	2019-08-15	Grace Breeding Ltd.	Compositions comprising a non-pathogenic bacteria and methods for protecting plant and animal hosts from fungal, bacterial and viral diseases
KR102288921B1 (ko) *	2018-05-28	2021-08-11	주식회사 엘지생활건강	구강질환 예방 또는 치료용 조성물
CN112006970B (zh) *	2020-08-14	2021-10-22	珀莱雅化妆品股份有限公司	一种抗瘙痒功效组合物及其制备方法与应用
EP4486314A1 (de) *	2022-03-01	2025-01-08	ISP Investments LLC	Sclareol oder sclareolid zur verbesserung der kopfhauterkrankungen und des haarwachstums

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3060172A (en)	1959-04-29	1962-10-23	Reynolds Tobacco Co R	Process for recovering sclareol from clary sage
US3952099A (en)	1973-03-13	1976-04-20	The Procter & Gamble Company	Dermatological compositions
US4130667A (en)	1976-01-12	1978-12-19	The Procter & Gamble Company	Dermatological compositions
GB2068228B (en)	1980-01-24	1984-02-29	Janssen Pharmaceutica Nv	Anti-microbial compositions for the topical treatment of acne vulgaris
US4537776A (en)	1983-06-21	1985-08-27	The Procter & Gamble Company	Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
US4837378A (en)	1986-01-15	1989-06-06	Curatek Pharmaceuticals, Inc.	Topical metronidazole formulations and therapeutic uses thereof
JP2700070B2 (ja) *	1988-06-10	1998-01-19	株式会社資生堂	グラム陽性嫌気性細菌用抗菌剤及びそれを用いた皮膚外用剤、口腔用組成物
US4983637A (en) *	1988-06-24	1991-01-08	Stephen Herman	Method for treating viral infection of HIV
US5212078A (en)	1989-08-28	1993-05-18	International Flavors And Fragrances Inc.	Process for producing a lactone
JPH0779682B2 (ja)	1989-08-28	1995-08-30	インターナショナルフレーバーズアンドフレーグランシィズインコーポレーテッド	微生物の生物学的に純粋な培養物、ラクトン生成方法、ジオール生成方法、化合物生成方法および環状エーテルの生成方法
US5155029A (en)	1989-08-28	1992-10-13	International Flavors & Fragrances Inc.	Process for producing a cyclic ether
US4970163A (en)	1989-08-28	1990-11-13	International Flavors & Fragrances Inc.	Process for producing diol and lactone and microorganisms capable of same
DE3942358A1 (de)	1989-12-21	1991-06-27	Henkel Kgaa	Verfahren zur herstellung von sclareolid
EP0636126B1 (de)	1992-04-16	1997-01-08	Henkel Kommanditgesellschaft auf Aktien	Verfahren zur herstellung von sclareolid
US5358752A (en) *	1993-02-23	1994-10-25	Norac Technologies Inc.	Skin care composition
GB9500024D0 (en)	1995-01-04	1995-03-01	Sod Conseils Rech Applic	Treatment of excessive cell proliferation disorders
CA2178528C (en) *	1995-06-09	2000-07-18	Hidehiko Takahashi	Therapeutics containing 5alpha - reductase inhibitors
JPH10298070A (ja) *	1997-04-22	1998-11-10	Toagosei Co Ltd	抗真菌剤
US6150381A (en) *	1998-06-09	2000-11-21	R.J. Reynolds Tobacco Company	Methods of treating microbial infection and therapeutic formulations therefor

1998
- 1998-06-09 US US09/094,058 patent/US6150381A/en not_active Expired - Lifetime
1999
- 1999-05-12 AT AT99921939T patent/ATE234089T1/de not_active IP Right Cessation
- 1999-05-12 EP EP99921939A patent/EP1083895B1/de not_active Expired - Lifetime
- 1999-05-12 WO PCT/US1999/010534 patent/WO1999063978A2/en not_active Ceased
- 1999-05-12 AU AU39022/99A patent/AU3902299A/en not_active Abandoned
- 1999-05-12 DE DE69905878T patent/DE69905878T2/de not_active Expired - Lifetime
2000
- 2000-11-13 US US09/711,700 patent/US6331551B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US6331551B1 (en)	2001-12-18
EP1083895A2 (de)	2001-03-21
WO1999063978A2 (en)	1999-12-16
EP1083895B1 (de)	2003-03-12
DE69905878D1 (de)	2003-04-17
US6150381A (en)	2000-11-21
DE69905878T2 (de)	2003-12-04
WO1999063978A3 (en)	2000-04-13
AU3902299A (en)	1999-12-30

Legal Events

Date	Code	Title	Description
2003-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE234089T1 (de)	2003-03-15	Zubereitungen enthaltend sclareol und sclareolide zur behandlung mikrobieller infektionen
DE59509751D1 (de)	2001-11-29	Gegen hautalterung wirksame stoffe oder wirkstoffkombinationen und zubereitungen
DK0725779T3 (da)	2001-10-29	Hidtil ukendte (R)-5-Carbamoyl-8-fluor-3-N,N-disubstitueret-amino-3,4-dihydro-2H-1-benzopyraner
BRPI0006634B8 (pt)	2021-05-25	composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios
NO20025450D0 (no)	2002-11-14	Ny farmasöytisk sammensetning
NO961326D0 (no)	1996-04-01	Inhibitorer av
DE60126980D1 (de)	2007-04-12	Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
NO20003233L (no)	2000-08-22	4-hydroksykinolin-3-karboksamider og hydrazider som antivirale midler
TW200509956A (en)	2005-03-16	Compositions and methods for treatment of rosacea
BR0109211A (pt)	2003-02-11	Compostos com atividade 5-ht1a úteis para o tratamento de distúrbios da retina externa
DE60041753D1 (de)	2009-04-23	Arzneimittel zur behandlung von c. pneumoniae infektionen
FR2856294B1 (fr)	2005-08-05	Utilisation cosmetique d'une composition comprenant au moins une oxazoline, a titre de principe actif, comme amincissant et/ou pour prevenir et/ou traiter la cellulite
ES2074276T3 (es)	1995-09-01	Metodo de tratamiento de la alopecia.
ATE515253T1 (de)	2011-07-15	Zusammensetzungen auf basis von etyllinoleat und triethylcitrat zur behandlung von seborrhöe und akne
ATE412646T1 (de)	2008-11-15	Zur behandlung von schmerzen geeignete therapeutische mittel
ATE238792T1 (de)	2003-05-15	Verwendung von makroliden zur behandlung von glaukom
ATE336997T1 (de)	2006-09-15	Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
ATE318610T1 (de)	2006-03-15	Orale zusammensetzungen zur behandlung von kopfhauterkrankungen
PT932613E (pt)	2005-06-30	Expressao de bloqueio de factoes de virulencia em s. aureus
TW200505473A (en)	2005-02-16	Compositions and methods for treatment of psoriasis
NO20044530L (no)	2004-10-21	Fremgangsmate for behandling av kognitive forstyrrelser
DE60018704D1 (de)	2005-04-21	Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
ATE322244T1 (de)	2006-04-15	Verwendung von polyaminosäurederivaten zur behandlung von seborrhoe und verwandten hautstörungen
RU94041028A (ru)	1996-09-20	Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
ATE216891T1 (de)	2002-05-15	Verwendung von immunosuppressiva zur behandlung der schizophrenie